Investor Update from NSB Chairman Paul Rennie
In The Media
As EmtinB continues to demonstrate positive results and nears clinical trials,
NeuroScientific Biopharmaceuticals has been gaining media coverage for our innovative approach as well as sharemarket performance.
NeuroScientific Biopharmaceuticals Investor Webinar Presentation – ShareCafe Small Cap “Hidden Gems”
NeuroScientific’s Director of Operations, Dr Alexandra Heaton Interview with Gareth Quinn of Republic PR
NeuroScientific Biopharmaceuticals taking a different approach to treat Alzheimer’s Disease
Matt Liddelow, NeuroScientific Biopharmaceuticals – 121 Tech Investment Singapore 2018